Publications by authors named "Howard R Soule"

38Publications

The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.

Prostate 2020 Oct 21. Epub 2020 Oct 21.

Science Department, Prostate Cancer Foundation, Santa Monica, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.24083DOI Listing
October 2020

Prostate Cancer Foundation-Department of Veterans Affairs Partnership: A Model of Public-Private Collaboration to Advance Treatment and Care of Invasive Cancers.

Fed Pract 2020 Aug;37(Suppl 4):S32-S37

is Vice President, Government Affairs and National Director of the Veterans Health Initiative; is a Consultant; is Program Assistant, Government Affairs; and are Research Assistants, Government Affairs; is Executive Vice President, Chief Science Officer; is Director, Global Research and Scientific Communications; is Manager of Medical Content; is Assistant Chief of Staff; and is President and Chief Executive Officer; all at the Prostate Cancer Foundation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/fp.0035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473725PMC
August 2020

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

J Clin Oncol 2020 Aug 9;38(24):2798-2811. Epub 2020 Jun 9.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.00046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430215PMC
August 2020

A Conversation Between Howard Soule and Johannes Czernin.

J Nucl Med 2020 06;61(6):774-776

David Geffen School of Medicine at UCLA, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.120.247031DOI Listing
June 2020

Advances in germline genetics for prostate cancer funded by the Prostate Cancer Foundation.

Can J Urol 2019 Oct;26(5 Suppl 2)

Prostate Cancer Foundation, Santa Monica, California, USA.

View Article

Download full-text PDF

Source
October 2019

The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.

Prostate 2019 09 23;79(12):1471-1486. Epub 2019 Jul 23.

Department of Science, Prostate Cancer Foundation, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23872DOI Listing
September 2019

The 24th Annual Prostate Cancer Foundation scientific retreat report.

Prostate 2018 09 15;78(12):867-878. Epub 2018 May 15.

Prostate Cancer Foundation, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23651DOI Listing
September 2018

Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?

J Clin Oncol 2018 04 5;36(10):937-941. Epub 2018 Feb 5.

Izak Faiena and Stuart Holden, David Geffen School of Medicine at UCLA, Los Angeles, CA; Mathew R. Cooperberg, University of California, San Francisco, San Francisco, CA; Stuart Holden, Howard R. Soule, and Jonathan W. Simons, Prostate Cancer Foundation, Santa Monica, CA; Todd M. Morgan, University of Michigan, Ann Arbor, MI; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; and Alicia K. Morgans and Maha Hussain, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804825PMC
April 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.

JCO Clin Cancer Inform 2017 11;1:1-15

Fatemeh Seyednasrollah and Laura L. Elo, Turku Centre for Biotechnology; University of Turku; Åbo Akademi University, Turku, Finland; Devin C. Koestler, University of Kansas Medical Center, Kansas City, KS; Tao Wang, University of Texas Southwestern Medical Center, Dallas, TX; Stephen R. Piccolo, Brigham Young University, Provo; University of Utah, Salt Lake City, Utah, UT; Roberto Vega, Russell Greiner, and Luke Kumar, University of Alberta; Alberta Innovates Centre for Machine Learning, Edmonton, Alberta, Canada; Christiane Fuchs, Helmholtz Zentrum München, Neuherberg; Technische Universität München, Garching, Germany; Eyal Gofer, The Hebrew University, Jerusalem, Israel; Russell D. Wolfinger, SAS Institute, Cary, NC; Kimberly Kanigel Winner and James C. Costello, University of Colorado, Anschutz Medical Campus, Aurora, CO; Chris Bare, Elias Chaibub Neto, Thomas Yu, Thea Norman, and Justin Guinney, Sage Bionetworks, Seattle, WA; Liji Shen and Fang Liz Zhou, Sanofi, Bridgewater, NJ; Kald Abdallah, AstraZeneca, Gaithersburg, MD; Gustavo Stolovitzky, IBM Research, Yorktown Heights; Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Howard R. Soule, Prostate Cancer Foundation, Santa Monica; Charles J. Ryan, University of California, San Francisco, CA; Christopher J. Sweeney, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Oliver Sartor, Tulane University, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874023PMC
November 2017

Legends in Urology.

Authors:
Howard R Soule

Can J Urol 2017 10;24(5):8973-8975

Prostate Cancer Foundation, Santa Monica, California, USA.

View Article

Download full-text PDF

Source
October 2017

The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.

Prostate 2017 Jul 14;77(10):1093-1106. Epub 2017 May 14.

Prostate Cancer Foundation, Santa Monica, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23366DOI Listing
July 2017

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

Prostate 2017 02 1;77(3):245-254. Epub 2016 Nov 1.

Prostate Cancer Foundation, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23272DOI Listing
February 2017

The 22nd annual prostate cancer foundation scientific retreat report.

Prostate 2016 09 8;76(12):1037-52. Epub 2016 Jun 8.

Prostate Cancer Foundation, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23193DOI Listing
September 2016

The culture of cell culture practices and authentication--Results from a 2015 Survey.

Biotechniques 2015 Oct 1;59(4):189-90, 192. Epub 2015 Oct 1.

Gilead, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2144/000114344DOI Listing
October 2015

The 21st Annual Prostate Cancer Foundation Scientific Retreat report.

Prostate 2015 Aug 20;75(11):1119-28. Epub 2015 Apr 20.

Prostate Cancer Foundation, Santa Monica, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22993DOI Listing
August 2015

Global developments in prostate cancer research and clinical practice.

Asian J Androl 2014 Jul-Aug;16(4):503-4

Prostate Cancer Foundation, Santa Monica, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.131073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104070PMC
August 2015

The 20th Annual Prostate Cancer Foundation Scientific Retreat report.

Prostate 2014 Jun 9;74(8):811-9. Epub 2014 Apr 9.

Prostate Cancer Foundation, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22808DOI Listing
June 2014

Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting.

Prostate 2014 Feb;74(3):314-20

Department of Urology, The James Buchanan Brady Urological Institute, Baltimore, Maryland; Department of Oncology, The Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253084PMC
February 2014

The 17th Annual Prostate Cancer Foundation scientific retreat: meeting report.

Prostate 2011 Nov 10;71(15):1616-20. Epub 2011 Mar 10.

Prostate Cancer Foundation, Santa Monica, California 90401, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pros.21378
Publisher Site
http://dx.doi.org/10.1002/pros.21378DOI Listing
November 2011

The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.

Prostate 2010 Jun;70(8):916-20

Prostate Cancer Foundation, Santa Monica, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21127DOI Listing
June 2010

CaP CURE Initiatives and Projects.

Authors:
Howard R Soule

Rev Urol 2003 ;5 Suppl 2:S60-5

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502334PMC
July 2011

CaP CURE Initiatives and Projects.

Authors:
Howard R Soule

Rev Urol 2003 ;5 Suppl 3:S92-7

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502340PMC
July 2011

Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.

Clin Cancer Res 2004 Jun;10(11):3927-33

Division of Cancer Treatment and Diagnostics, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-03-0788DOI Listing
June 2004